Assessment of Cardiopulmonary Fitness in Healthy Adults

August 26, 2024 updated by: Ebru Calik Kutukcu, Hacettepe University
This project was aimed to investigate cardiorespiratory fitness and the factors affecting cardiorespiratory fitness in healthy adults. The data obtained with this project will be normative values for the data obtained with CPET in healthy people.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Cardiorespiratory fitness is one of the 'health-related physical fitness' components of physical fitness and can be expressed as 'the ability of the heart, lung and vascular system to deliver oxygen and nutrients to working muscles'. Cardiopulmonary exercise testing (CPET) is a common procedure used to assess cardiopulmonary fitness, identify physiological factors limiting exercise, identify potential therapeutic targets for these factors, and evaluate the effects of an intervention. Therefore, in this project, it was aimed to investigate cardiorespiratory fitness and the factors affecting cardiorespiratory fitness in healthy adults. The data obtained with this project will be normative values for the data obtained with CPET in healthy people.

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Turkey
      • Ankara, Turkey
        • Recruiting
        • Hacettepe University
        • Contact:
        • Principal Investigator:
          • Ebru Calik Kutukcu, PhD
        • Sub-Investigator:
          • Deniz İnal İnce, PhD
        • Sub-Investigator:
          • Naciye Vardar Yagli, PhD
        • Sub-Investigator:
          • Melda Saglam, PhD
        • Sub-Investigator:
          • Aynur Demirel, PhD
        • Sub-Investigator:
          • Aslıhan Cakmak Onal, PhD
        • Sub-Investigator:
          • Aydan Asli Aksel Uylar, MSc

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study will include healthy adult subjects without any known internal disease.

Description

Inclusion Criteria:

  • 18-65 years of age,
  • Volunteering to participate in the study,
  • Co-operation,
  • Being able to ambulate.

Exclusion Criteria:

  • Having any known respiratory, cardiac, neurological or other internal disease or malignant disease,
  • Having any problem or musculoskeletal system disorder that prevents walking,
  • To have undergone any surgery within the last six months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cardiorespiratory Fitness
Time Frame: This test takes 15 to 20 minutes.
In this parameter, which is assessed by cardiopulmonary exercise testing, the oxygen consumption measured during the test and the workload achieved in the test will be taken into consideration.
This test takes 15 to 20 minutes.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory Function Test
Time Frame: This test takes 3 to 5 minutes.
The pulmonary function test is a test that assesses respiratory function by performing certain manoeuvres.
This test takes 3 to 5 minutes.
Respiratory Muscle Strength Test
Time Frame: This test takes 3 to 5 minutes.
Inspiratory and expiratory muscle strengths will be measured separately by breathing manoeuvres.
This test takes 3 to 5 minutes.
Physical Activity
Time Frame: This questionnaire takes 1 minute.
Physical activity level will be measured with International Physical Activity Questionnaire.
This questionnaire takes 1 minute.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hacettepe University

Investigators

  • Principal Investigator: Ebru Calik Kutukcu, PhD, Hacettepe Univesity

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 18, 2023

Primary Completion (Estimated)

March 1, 2025

Study Completion (Estimated)

March 1, 2025

Study Registration Dates

First Submitted

August 26, 2024

First Submitted That Met QC Criteria

August 26, 2024

First Posted (Actual)

August 27, 2024

Study Record Updates

Last Update Posted (Actual)

August 27, 2024

Last Update Submitted That Met QC Criteria

August 26, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • GO 23/211

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Healthy group

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe